New Delhi, Dec 13 (PTI) Drug maker Rusan Pharma Thursday said it has launched a drug to treat Parkinson’s disease.Also Read - Horoscope Today, May 18, Wednesday: Gemini Will be Swamped With Work, Office Politics Will Agitate Scorpio

The drug — Aposan — is used to treat motor fluctuations in patients with Parkinson’s Disease which are not sufficiently controlled by oral medications currently available in the country. Also Read - Explained: What Are Twitter Bots, And Why Elon Musk Has A Problem With Them

The company said it has developed the drug, which would be available in the form of injections, pen and continuous infusion pumps, indigenously and has received approval from the Drug Controller General of India (DCGI). Also Read - IPL 2022 Points Table After MI vs SRH, Match 65: Gujarat Titans (GT) Maintain Top Spot; Jos Buttler With Orange Cap, Yuzvendra Chahal Retains Purple Cap

“The company has always put forward indigenously developed high technology advanced delivery products in the Indian market,” Rusan Pharma MD Kunal Saxena said in a statement.

The company wants to ensure that the treatment is affordable and accessible to all Parkinson’s disease patients, he added.

This is published unedited from the PTI feed.